10/25/2024 3:43 PM | Moleculin Biotech (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/25/2024 3:16 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 7:40 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 7:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 7:31 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
09/09/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
08/19/2024 3:10 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 9:06 AM | Moleculin Biotech (Filer)
| Form 424B3 | |
08/16/2024 3:54 PM | Moleculin Biotech (Filer)
| Form 424B4 | |
08/15/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
08/15/2024 10:21 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024 8:57 PM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024 7:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2024 8:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 7:35 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 6:00 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
07/22/2024 4:31 PM | Moleculin Biotech (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/10/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2024 4:01 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
06/25/2024 5:00 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:01 PM | Foster Jonathan P. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:02 PM | Moleculin Biotech (Issuer) PICKER DONALD H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:00 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:01 PM | Foster Jonathan P. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:01 PM | Moleculin Biotech (Issuer) PICKER DONALD H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 4:05 PM | Moleculin Biotech (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/16/2024 7:32 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 7:38 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:16 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 7:31 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:55 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 8:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 4:15 PM | Moleculin Biotech (Filer)
| Form 10-K/A | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
04/25/2024 7:23 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2024 4:14 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 8:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 2:03 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 3:31 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 8:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 4:19 PM | Moleculin Biotech (Filer)
| Form 424B3 | |
02/15/2024 8:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:36 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:43 PM | ARMISTICE CAPITAL, LLC (Filed by) Moleculin Biotech (Subject)
| Form SC 13G | |
02/12/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
02/02/2024 4:05 PM | Moleculin Biotech (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
01/24/2024 7:50 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 4:14 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
12/27/2023 6:31 AM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 6:31 AM | George Robert E. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 6:32 AM | Foster Jonathan P. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:00 PM | Moleculin Biotech (Filer)
| Form 424B5 | |
12/21/2023 4:17 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 7:55 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 7:55 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 7:50 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2023 8:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 7:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 7:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 7:00 AM | Moleculin Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 7:45 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 7:35 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |